News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ignyta Receives $10 Million Through Expanded Capital Term Loan From Silicon Valley Bank


1/6/2014 8:37:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (OTCQB:RXDX), an oncology precision medicine biotechnology company, announced today that Silicon Valley Bank (SVB) has bolstered its support of Ignyta through an expanded $10M capital term loan facility. The new facility replaces the previous $1.5M facility entered into between a wholly-owned subsidiary of Ignyta and SVB in June 2012 and February 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
Ignyta
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES